ObsEva SA to Participate in BMO Healthcare Conference December 12, 2018
December 06, 2018 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – December 6, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...